Biomarkers in vascular dementia: A recent update

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biomarkers and Genomic Medicine

• Publication date

  2015-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BGM.2014.11.001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroimaging in Dementia

  2017cited by this paper
• Significance of metallothioneins in aging brain.

  2014cited by this paper
• Psychology of Craving

  2014cited by this paper
• Cerebrolysin for vascular dementia.

  2013cited by this paper
• Alzheimer’s disease and CADASIL are heritable, adult-onset dementias that both involve damaged small blood vessels

  2013cited by this paper
• Biomarkers in Parkinson's disease (recent update).

  2013cited by this paper
• Aging‐induced dysregulation of Dicer1‐dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells

  2013cited by this paper
• Cerebrospinal Fluid Levels of Heart Fatty Acid Binding Protein are Elevated Prodromally in Alzheimer's Disease and Vascular Dementia

  2013cited by this paper
• Cerebrospinal fluid biomarkers in Alzheimer’s disease, vascular dementia and ischemic stroke patients: a critical analysis

  2013cited by this paper
• Serum Homocysteine, Dehydroepiandrosterone Sulphate and Lipoprotein (a) in Alzheimer's Disease and Vascular Dementia.

  2013influential reference
• Clinical significance of metallothioneins in cell therapy and nanomedicine

  2013cited by this paper
• Protein Markers for the Differential Diagnosis of Vascular Dementia and Alzheimer's Disease

  2012influential reference
• Autologous Bone Marrow Derived Mononuclear Cell Therapy for Vascular Dementia

  2012cited by this paper
• The Use of High-Throughput Technologies to Investigate Vascular Inflammation and Atherosclerosis

  2012cited by this paper
• Plasma microRNA biomarkers for detection of mild cognitive impairment

  2012cited by this paper
• Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

  2012cited by this paper
• MicroRNAs in Vascular Biology

  2012cited by this paper
• Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies.

  2012cited by this paper
• Chromosome 9p21.3 genotype is associated with vascular dementia and Alzheimer's disease.

  2011influential reference
• Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.

  2011cited by this paper
• Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke

  2011cited by this paper
• Identifying and validating biomarkers for Alzheimer's disease

  2011influential reference
• IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways.

  2011cited by this paper
• Association between circulating hemostatic measures and dementia or cognitive impairment: systematic review and meta‐analyzes

  2011cited by this paper
• Biomarkers of the Dementia

  2011cited by this paper
• THERAPEUTIC POTENTIAL OF METALLOTHIONEINS AS ANTIINFLAMMATORY AGENTS IN POLYSUBSTANCE ABUSE

  2011cited by this paper
• Cognitive impairment with vascular impairment and degeneration.

  2011cited by this paper
• Dementia screening, biomarkers and protein misfolding

  2011cited by this paper
• METALLOTHIONEINS AS EARLY AND SENSITIVE BIOMARKERS OF REDOX SIGNALING IN NEURODEGENERATIVE DISORDERS

  2011cited by this paper
• Implications for public health and diagnosis

  2011cited by this paper
• Serum Thyroid-Stimulating Hormone as a Predictor of Cognitive Impairment in an Elderly Cohort

  2011cited by this paper
• Autologous Bone Marrow Mononuclear Cells Enhance Recovery after Acute Ischemic Stroke in Young and Middle-Aged Rats

  2010cited by this paper
• Vascular cognitive impairment (VCI): Progress towards knowledge and treatment

  2010influential reference
• CSF Biomarkers Profile in CADASIL—A Model of Pure Vascular Dementia: Usefulness in Differential Diagnosis in the Dementia Disorder

  2010influential reference
• Vascular Cognitive Disorder. A Biological and Clinical Overview

  2010cited by this paper
• Metabolic Syndrome and Risk of Dementia in Older Adults

  2010cited by this paper
• Toward a pathological definition of vascular dementia.

  2010cited by this paper
• Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients.

  2010cited by this paper
• CSF biomarker profile and diagnostic value in vascular dementia

  2009cited by this paper
• Alzheimer's Mechanisms in Ischemic Brain Degeneration

  2009cited by this paper
• Risk of Dementia Associated with Elevated Plasma Homocysteine in a Latin American Population

  2009cited by this paper
• The concept of vascular cognitive impairment.

  2009cited by this paper
• Genetics of atherothrombotic and lacunar stroke.

  2009influential reference
• Vascular dementia: A review of recent evidence for prevention and treatment

  2009cited by this paper
• Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage.

  2008cited by this paper
• High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

  2008cited by this paper
• [Genetic factors for cerebral amyloid angiopathy].

  2008cited by this paper
• CSF/Serum Folate Gradient: Physiology and Determinants with Special Reference to Dementia

  2008cited by this paper
• Detecting dementia with the mini-mental state examination in highly educated individuals.

  2008cited by this paper
• Biomarkers of cerebrovascular disease in dementia.

  2007influential reference
• Notch signaling in vascular development and physiology

  2007cited by this paper
• The 2005 Thomas Willis Lecture: Stroke and Vascular Cognitive Impairment: A Transdisciplinary, Translational and Transactional Approach

  2007cited by this paper
• Rapidly-administered short forms of the Wechsler Adult Intelligence Scale-3rd edition.

  2007cited by this paper
• Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience

  2006cited by this paper
• Postmortem Examination of Vascular Lesions in Cognitive Impairment: A Survey Among Neuropathological Services

  2006cited by this paper
• Genetic variants predisposing to cardiovascular disease

  2006influential reference
• Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

  2006cited by this paper
• Genetics of Vascular Cognitive Impairment: The Opportunity and the Challenges

  2006cited by this paper
• Cognitive impact of subcortical vascular and Alzheimer's disease pathology

  2006cited by this paper
• Distinguishing between Vascular Dementia and Alzheimer's Disease by Means of the WAIS: A Meta-analysis

  2006cited by this paper
• Functional analysis of a recurrent missense mutation in Notch3 in CADASIL

  2005cited by this paper
• Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.

  2004cited by this paper
• Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study

  2004cited by this paper
• Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease

  2004cited by this paper
• Lipoprotein(a): an elusive cardiovascular risk factor.

  2004cited by this paper
• β-Estradiol, Dehydroepiandrosterone, and Dehydroepiandrosterone Sulfate Protect against N-Methyl-d-aspartate-Induced Neurotoxicity in Rat Hippocampal Neurons by Different Mechanisms

  2004cited by this paper
• New roles for VEGF in nervous tissue--beyond blood vessels.

  2004cited by this paper
• Neurological diseases: Mechanisms, challenges and opportunities in stroke

  2003cited by this paper
• Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

  2003cited by this paper
• Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?

  2003cited by this paper
• Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

  2003cited by this paper
• Homocysteine and brain atrophy on MRI of non-demented elderly.

  2003cited by this paper
• Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis

  2002cited by this paper
• Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales

  2001cited by this paper
• Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia.

  2001cited by this paper
• White Matter Damage Is Associated With Matrix Metalloproteinases in Vascular Dementia

  2001cited by this paper
• CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy

  2000cited by this paper
• Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

  1998cited by this paper
• Orthostatic hypotension and low blood pressure in organic dementia: a study of prevalence and related clinical characteristics.

  1997cited by this paper
• Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias

  1997cited by this paper
• Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN).

  1996cited by this paper
• Orthostatic hypotension in organic dementia: Relationship between blood pressure, cortical blood flow and symptoms

  1996cited by this paper
• Regional cerebral blood flow in frontal lobe dementia of non-Alzheimer type.

  1993cited by this paper
• Hachinski's ischemic score and the diagnosis of vascular dementia: A review

  1993cited by this paper
• Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia

  1992cited by this paper
• Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

  1992cited by this paper

• Neuroprotective Effects of Shrimp Oil Against Oxidative Stress in Chronic Cerebral Hypoperfusion Rats

  2025cites this paper
• Reduced levels of angiogenesis biomarkers predict increased symptom severity in Chinese Americans with Alzheimer’s disease with demographic-specific effect

  2025cites this paper
• Emerging nano-derived therapy for the treatment of dementia: a comprehensive review

  2025cites this paper
• Advances in Plasma Biomarkers of Vascular Cognitive Impairment

  2024cites this paper
• Fluid biomarkers of the neurovascular unit in cerebrovascular disease and vascular cognitive disorders: A systematic review and meta-analysis

  2024cites this paper
• Gene Expression Profiling as a Novel Diagnostic Tool for Neurodegenerative Disorders

  2023cites this paper
• Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment

  2023cites this paper
• Palm Oil Derived Tocotrienol-Rich Fraction Attenuates Vascular Dementia in Type 2 Diabetic Rats

  2022cites this paper
• Does the Internal Carotid Artery Attenuate Blood‐Flow Pulsatility in Small Vessel Disease? A 7 T 4D‐Flow MRI Study

  2022cites this paper
• Interaction between Alzheimer’s Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers

  2022cites this paper
• Биомаркеры сосудистой когнитивной дисфункции

  2021cites this paper
• 3D hydrogel models of the neurovascular unit to investigate blood–brain barrier dysfunction

  2021cites this paper
• Biomarkers of vascular cognitive impairment

  2021cites this paper
• Velocity Pulsatility and Arterial Distensibility Along the Internal Carotid Artery

  2020cites this paper
• Small Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling?

  2020cites this paper
• Functional near-infrared spectroscopy reveals decreased resting oxygenation levels and task-related oxygenation changes in mild cognitive impairment and dementia: A systematic review.

  2020cites this paper
• Neurochemical Aspects of Vascular Dementia

  2019cites this paper
• Plasma Biomarkers: Potent Screeners of Alzheimer’s Disease

  2019cites this paper
• Exploring Relationships Among Peripheral Amyloid Beta, Tau, Cytokines, Cognitive Function, and Psychosomatic Symptoms in Breast Cancer Survivors

  2019cites this paper
• Cerebral Lipid Dynamics in Chronic Cerebral Hypoperfusion Model by DESI-MS imaging.

  2019cites this paper
• A novel pharmacodynamic model in rats for preventing vascular dementia from maintaining neurovascular coupling sensitivity

  2018cites this paper
• The Effect of Apocynin on Motor and Cognitive Functions in Experimental Alzheimer’s disease

  2018cites this paper
• Dementia risk and prevention by targeting modifiable vascular risk factors

  2018cites this paper
• N-Terminal Prosomatostatin and Risk of Vascular Dementia

  2017cites this paper
• The vascular facet of late-onset Alzheimer's disease: an essential factor in a complex multifactorial disorder

  2017cites this paper
• Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer’s disease

  2017cites this paper
• Antioxidants and Mitochondrial Bioenergetics

  2017cites this paper
• Updates in vascular dementia

  2017cites this paper
• Neurodegenerative and Vascular Involvement in Post Stroke Dementia

  2016cites this paper
• miRNAs Plasma Profiles in Vascular Dementia: Biomolecular Data and Biomedical Implications

  2016cites this paper
• Practice of Epidemiology Considerations for Use of Blood-Based Biomarkers in Epidemiologic Dementia

  year unknowncites this paper